Ayse Ozden Birkan

Ayse Ozden Birkan

Auto-generated profile, based on publicly available information

Ayse Ozden Birkan

Yasar University, Izmir, Turkey

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2022 in Borsa Istanbul Review
Verified
Journal Article
Open access
ESEbru Saygili
Ebru Saygili
SASerafettin Arslan
Serafettin Arslan
ABAyse Ozden Birkan
Ayse Ozden Birkan

1 April 2026 in Sage Open
Verified
Journal Article
Open access
ABAyşe Özden Birkan
Ayşe Özden Birkan
TGTuğçe Uygurtürk Gazel
Tuğçe Uygurtürk Gazel
Countries have responded to the COVID-19 pandemic with different combinations of export controls and import liberalization measures, using non-tariff measures (NTMs). This study aims to understand the effects of NTMs on trade in medical products during the Covid-19 pandemic by obtaining their ad valorem equivalents (AVEs), comparing AVEs for pre-pandemic and pandemic years, and comparing AVEs with tariffs. We consider 59 key Covid-19 medical products listed by the World Customs Organization at the HS six-digit level for 15 countries selected based on their trade volume in Covid-19 medical supplies. We use a panel data set of 15 countries over the period 2002 to 2019 to estimate import demand elasticities for 59 commodities using 3 alternative methods: fixed effects, fixed effects instrumental variables, and system GMM. After estimating import demand elasticities, we estimate two sets of gravity-type import models for each commodity, one for the pre-pandemic year of 2019 and one for the pandemic year of 2020. We use the coefficients to obtain ad valorem equivalents of NTMs for each commodity and country in 2019 and 2020. We then compare the AVEs for the 2 years and with tariffs. We find that NTM AVEs increased during the pandemic, surpassing average tariffs in most countries and across most medical products. Our results show that NTMs were more heavily used during the pandemic and were more effective than tariffs on medical commodities during this period. JEL Classification: F01, F13, F14, F19